Kester Capital
PE
2007
$314 M
London, England, United Kingdom
Profile
Kester Capital is a private equity firm based in London, United Kingdom, founded in 2006. The firm is led by Managing Partners Cameron Crockett and Adam Maidment, with a team of 14 professionals. Kester Capital is known for its deep expertise in the Technology and Life Sciences sectors, focusing on building strong partnerships with ambitious companies and dynamic leaders.
The firm targets equity investments of up to £75 million, primarily in the Technology and Life Sciences sectors. Kester Capital invests in companies across the United Kingdom and Australia, aiming to support businesses with the potential to become market leaders. The firm manages several funds, including Kester Capital Fund II with an AUM of $95 million launched in 2020, and Kester Capital Fund III with an AUM of $220 million launched in 2024.
Notable portfolio companies include Nutritics - food data management, Addresscloud - geolocation intelligence, Re-flow - field management software, Optibrium - drug discovery software, and VIXIO - regulatory intelligence. Kester Capital's investment strategy is distinguished by its sector-focused approach and a strong track record of creating value for its portfolio companies.
Industry
Kester Capital Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Kester Capital Fund II
|
Private Equity (PE)
|
Business Services (B2B)
Healthcare Services
Medical Devices
SaaS
Software
Technology
|
Series B
Late Stage (Series C+)
|
Europe
|
$5-10 m
|
$95 M
|
August 2020
|
|
Kester Capital Fund III
|
Private Equity (PE)
|
Healthcare Services
Medical Devices
Retail
SaaS
Software
|
Series B
Late Stage (Series C+)
|
Europe
|
$5-10 m
|
$220 M
|
March 2024
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.